Erratum. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526–532
| Autor: | Justin M. Gregory, James C. Slaughter, Sara H. Duffus, T. Jordan Smith, Lauren M. LeStourgeon, Sarah S. Jaser, Allison B. McCoy, James M. Luther, Erin R. Giovannetti, Schafer Boeder, Jeremy H. Pettus, Daniel J. Moore |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Male
Advanced and Specialized Nursing Endocrinology Diabetes and Metabolism COVID-19 Comorbidity Middle Aged Severity of Illness Index Hospitalization Diabetes Mellitus Type 1 Diabetes Mellitus Type 2 Hypertension Odds Ratio Internal Medicine Electronic Health Records Humans Female Prospective Studies Erratum |
| Zdroj: | Diabetes Care |
| ISSN: | 0149-5992 |
| Popis: | To quantify and contextualize the risk for coronavirus disease 2019 (COVID-19)-related hospitalization and illness severity in type 1 diabetes.We conducted a prospective cohort study to identify case subjects with COVID-19 across a regional health care network of 137 service locations. Using an electronic health record query, chart review, and patient contact, we identified clinical factors influencing illness severity.We identified COVID-19 in 6,138, 40, and 273 patients without diabetes and with type 1 and type 2 diabetes, respectively. Compared with not having diabetes, people with type 1 diabetes had adjusted odds ratios of 3.90 (95% CI 1.75-8.69) for hospitalization and 3.35 (95% CI 1.53-7.33) for greater illness severity, which was similar to risk in type 2 diabetes. Among patients with type 1 diabetes, glycosylated hemoglobin (HbADiabetes status, both type 1 and type 2, independently increases the adverse impacts of COVID-19. Potentially modifiable factors (e.g., HbA |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|